Fresenius Kabi recalls Rifampin; China's 3SBio buys some small molecule manufacturing;

> Fresenius Kabi is voluntarily recalling two lots, or 7,593 vials, of Rifampin because they were out of specification for impurities and color. Recall

> Qualitest Pharmaceuticals is recalling 47,376 bottles of hydroxyzine hydrochloride because some identification codes are unreadable. Notice

> Chinese biotech 3SBio has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), in part to get its expertise in small molecule manufacturing. Release

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.